CSIMarket Company Name, Ticker, Industry, else..


Xtant Medical Holdings Inc   (NYSEAMER: XTNT)
Other Ticker:  
 

Xtant Medical Holdings Inc

XTNT's Fundamental analysis



Looking into Xtant Medical Holdings Inc growth rates, revenue grew by 14.95 % in the fourth quarter of 2024 from the same quarter a year ago. Ranking at No. 676

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -2.05 %

Xtant Medical Holdings Inc net loss decreased from $-4 millions, to $-3 millions in fourth quarter of 2024,

• More on XTNT's Growth


Xtant Medical Holdings Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 276.04 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.7.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.2.


• More on XTNT's Valuation
 
 Total Debt (Millions $) 34
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 505,241
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 5.59
 Tangible Book Value (Per Share $) 0.20

Xtant Medical Holdings Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 276.04 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.7.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.2.

Xtant Medical Holdings Inc Price to Book Ratio is at 1.91 lower than Industry Avg. of 1878.65. and higher than S&P 500 Avg. of 0.01

• More on XTNT's Valuation

•  Market Capitalization (Millions $) 82
•  Shares Outstanding (Millions) 137
•  Employees 232
•  Revenues (TTM) (Millions $) 117
•  Net Income (TTM) (Millions $) -16
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -4
•  Total Debt (Millions $) 34
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 505,241
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 5.59
•  Tangible Book Value (Per Share $) 0.20

•  Market Capitalization (Millions $) 82
•  Shares Outstanding (Millions) 137
•  Employees 232
•  Revenues (TTM) (Millions $) 117
•  Net Income (TTM) (Millions $) -16
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -4





  Ratio
•   Capital Ratio (MRQ) 2.41
•  Total Debt to Equity (MRQ) 0.8
•  Tangible Leverage Ratio (MRQ) 1.83
•  Asset Turnover Ratio (TTM) 1.23
•  Inventory Turnover Ratio (TTM) 1.23





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com